ICM
BMY icon

Ionic Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Ionic Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-60,000
Closed -$3.79M – 221
2018
Q1 		$3.79M Sell
60,000
-40,000
-40% -$2.57M 0.24% 90
2017
Q4 		$6.13M Buy
100,000
+10,000
+11% +$625K 0.25% 90
2017
Q3 		$5.74M Buy
90,000
+41,100
+84% +$2.4M 0.23% 90
2017
Q2 		$2.73M Sell
48,900
-71,100
-59% -$3.87M 0.15% 150
2017
Q1 		$6.53M Buy
120,000
+70,000
+140% +$3.84M 0.4% 64
2016
Q4 		$2.92M Buy
+50,000
New +$2.73M 0.16% 160

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ionic Capital Management's BMY Position: Q4 2019 in Review

Ionic Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 19,600 shares — an estimated $994K sold.

Ionic Capital Management first reported a position in BMY in Q1 2017 and held it in 11 quarters. The position peaked at $6.29M in Q1 2017. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Ionic Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
  • Ionic Capital Management sold 19,600 Bristol-Myers Squibb shares in Q4 2019, an estimated $994K.
  • Ionic Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 11 quarters.
  • Ionic Capital Management's Bristol-Myers Squibb position peaked at $6.29M in Q1 2017.
  • 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Ionic Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.